£15.0M
Novartis International and Cambridge Innovation Capital participated in the £15m fund.
Start Codon accelerates life science and healthcare start-ups through funding and expert guidance.
Start Codon operates as a business accelerator focused on life science and healthcare start-ups based in Cambridge. The organisation provides seed funding, mentoring, and lab facilities to translate early-stage research into commercial enterprises.
Jonathan Milner
Dr

Ian Tomlinson
Dr
Ian chairs Start Codon and Maxion Therapeutics, and previously held senior business development roles at GSK.
LinkedInNovartis International and Cambridge Innovation Capital participated in the £15m fund.